Analysts expect that Anthem Inc (NYSE:ANTM) will post earnings per share (EPS) of $3.85 for the current quarter, according to Zacks. Four analysts have provided estimates for Anthem’s earnings, with the highest EPS estimate coming in at $3.97 and the lowest estimate coming in at $3.74. Anthem reported earnings of $2.44 per share during the same quarter last year, which suggests a positive year over year growth rate of 57.8%. The business is expected to report its next quarterly earnings report on Wednesday, January 29th.
According to Zacks, analysts expect that Anthem will report full-year earnings of $19.36 per share for the current financial year, with EPS estimates ranging from $19.30 to $19.45. For the next financial year, analysts expect that the company will post earnings of $22.85 per share, with EPS estimates ranging from $22.03 to $23.20. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that that provide coverage for Anthem.
Anthem (NYSE:ANTM) last posted its earnings results on Wednesday, October 23rd. The company reported $4.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.82 by $0.05. The company had revenue of $26.44 billion during the quarter, compared to the consensus estimate of $25.88 billion. Anthem had a net margin of 4.21% and a return on equity of 15.02%. The firm’s quarterly revenue was up 15.1% on a year-over-year basis. During the same period in the previous year, the firm posted $3.81 earnings per share.
NYSE ANTM traded down $4.02 on Friday, reaching $259.49. 1,548,151 shares of the company’s stock traded hands, compared to its average volume of 1,711,333. The firm has a market cap of $66.58 billion, a price-to-earnings ratio of 16.33, a P/E/G ratio of 0.96 and a beta of 0.73. The stock has a 50 day moving average price of $247.41 and a 200-day moving average price of $269.84. Anthem has a fifty-two week low of $227.16 and a fifty-two week high of $317.99. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.64 and a current ratio of 1.64.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, December 5th will be given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.23%. Anthem’s dividend payout ratio (DPR) is currently 20.14%.
In other Anthem news, Director Robert L. Dixon, Jr. sold 520 shares of the company’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $294.11, for a total value of $152,937.20. Following the completion of the transaction, the director now owns 9,971 shares in the company, valued at $2,932,570.81. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.17% of the company’s stock.
Institutional investors have recently modified their holdings of the business. Squar Milner Financial Services LLC purchased a new stake in shares of Anthem during the second quarter worth about $28,000. Next Capital Management LLC purchased a new stake in shares of Anthem during the second quarter worth about $30,000. Motco purchased a new stake in shares of Anthem during the second quarter worth about $31,000. NuWave Investment Management LLC increased its stake in shares of Anthem by 46.3% during the second quarter. NuWave Investment Management LLC now owns 120 shares of the company’s stock worth $34,000 after purchasing an additional 38 shares in the last quarter. Finally, Clean Yield Group purchased a new stake in shares of Anthem during the second quarter worth about $36,000. Institutional investors and hedge funds own 88.39% of the company’s stock.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Article: How to invest in blue-chip stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.